GW Pharmaceuticals PLC Debt to Equity Ratio 2016-2021 | GWPH
Current and historical debt to equity ratio values for GW Pharmaceuticals PLC (GWPH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. GW Pharmaceuticals PLC debt/equity for the three months ending March 31, 2021 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-03-31 | $0.20B | $0.74B | 0.27 |
| 2020-12-31 | $0.20B | $0.74B | 0.27 |
| 2020-09-30 | $0.18B | $0.73B | 0.24 |
| 2020-06-30 | $0.15B | $0.72B | 0.21 |
| 2020-03-31 | $0.14B | $0.72B | 0.20 |
| 2019-12-31 | $0.16B | $0.73B | 0.22 |
| 2019-09-30 | $0.13B | $0.72B | 0.18 |
| 2019-06-30 | $0.11B | $0.73B | 0.16 |
| 2019-03-31 | $0.11B | $0.64B | 0.17 |
| 2018-12-31 | $0.08B | $0.67B | 0.12 |
| 2018-09-30 | $0.00B | 0.00 | |
| 2018-06-30 | $0.08B | $0.50B | 0.15 |
| 2018-03-31 | $0.07B | $0.56B | 0.12 |
| 2017-12-31 | $0.08B | $0.62B | 0.12 |
| 2017-06-30 | $0.06B | $0.41B | 0.15 |
| 2017-03-31 | $0.06B | $0.44B | 0.13 |
| 2016-12-31 | $0.07B | $0.48B | 0.15 |
| 2016-06-30 | $0.07B | $0.27B | 0.27 |
| 2016-03-31 | $0.07B | $0.31B | 0.23 |
| 2015-12-31 | $0.08B | $0.34B | 0.23 |
